The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins
Open accessAbstract
Heterogeneity in the N-glycans on therapeutic proteins causes difficulties for protein purification and process reproducibility and can lead to variable therapeutic efficacy. This heterogeneity arises from the multistep process of mammalian complex-type N-glycan synthesis. Here we report a glycoengineering strategy--which we call GlycoDelete--that shortens the Golgi N-glycosylation pathway in mammalian cells. This shortening results in the expression of proteins with small, sialylated trisaccharide N-glycans and reduced complexity compared to native mammalian cell glycoproteins. GlycoDelete engineering does not interfere with the functioning of N-glycans in protein folding, and the physiology of cells modified by GlycoDelete is similar to that of wild-type cells. A therapeutic human IgG expressed in GlycoDelete cells had properties, such as reduced initial clearance, that might be beneficial when the therapeutic goal is antigen neutralization. This strategy for reducing N-glycan heterogeneity on mammalian proteins could lead to more consistent performance of therapeutic proteins and modulation of biopharmaceutical functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using this expression system for transient anti-CD-20 production, recombinant proteins had very short sialylated N-glycans with high homogeneity on the Fc domain and reduced affinity to FcγRs compared to proteins expressed in wild-type 293S.”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Meuris et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“GlycoDelete is an elegant glycoengineering strategy worth mentioning, which reduces glycan heterogeneity by expressing a Golgi-targeted endo-β-N-acetylglucosaminidase in HEK 293SGnTI(−) cells to produce GlcNAc N-glycan ‘stumps’ modified by galactosyltransferases and sialyltransferases to yield small sialylated trisaccharides [108].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [108]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, to improve N-glycan homogeneity on therapeutic proteins, a technique called “GlycoDelete” engineering was also recently developed in HEK293S cells (Meuris et al., 2014).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Meuris et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Dominant suppression of inflammation by glycan-hydrolyzed IgG
Nandakumar, K. S., Collin, M., Happonen, K. E., Croxford, A. M., Lundström, S. L., Zubarev, R. A., Rowley, M. J., Blom, A. M., & Holmdahl, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301480110 · Cited by 20
RetractedSkyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Mössner, E., Brünker, P., Moser, S., Püntener, U., Schmidt, C., Herter, S., Grau, R., Gerdes, C. A., Nopora, A., van Puijenbroek, E., et al. (2010) · Blood · doi:10.1182/blood-2009-06-225979 · Cited by 983
An improved colorimetric assay for interleukin 2
Tada, H., Shiho, O., Kuroshima, K.-I., Koyama, M., & Tsukamoto, K. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90183-3 · Cited by 871
Thermofluor-based high-throughput stability optimization of proteins for structural studies
Ericsson, U. B., Hällberg, B. M., DeTitta, G. T., Dekker, N., & Nordlund, P. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.07.027 · Cited by 840
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y., Miyazono, K., Urabe, A., & Takaku, F. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400219 · Cited by 784
Reeves, P. J., Callewaert, N., Contreras, R., & Khorana, H. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519299 · Cited by 641
Self-citationIntracellular Signaling by the Unfolded Protein Response
Bernales, S., Papa, F. R., & Walter, P. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120200 · Cited by 543
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T.-B. G., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,353
Dekkers, G., Treffers, L. W., Plomp, R., Bentlage, A. E. H., de Boer, M., Koeleman, C. A. M., Lissenberg‐Thunnissen, S. N., Visser, R., Brouwer, M. C., Mok, J. Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00877 · Cited by 365
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 266
Impact of host cell line choice on glycan profile
Goh, J. B., & Ng, S. K. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1416577 · Cited by 243
Oligosaccharide Synthesis and Translational Innovation
Krasnova, L. B., & Wong, C. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11005 · Cited by 202
Jaroentomeechai, T., Stark, J. C., Natarajan, A., Glasscock, C. J., Yates, L. E., Hsu, K. J., Mrksich, M., Jewett, M. C., & DeLisa, M. P. (2018) · Nature Communications · doi:10.1038/s41467-018-05110-x · Cited by 201
Cell-Free Synthetic Biology: Engineering Beyond the CellPreprint
Perez, J. G., Stark, J. C., & Jewett, M. C. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023853 · Cited by 200
Quo vadis? The challenges of recombinant protein folding and secretion in Pichia pastoris
Puxbaum, V., Mattanovich, D., & Gasser, B. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6470-z · Cited by 178
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Hurlburt, N. K., Seydoux, E., Wan, Y.-H., Edara, V. V., Stuart, A. B., Feng, J., Suthar, M. S., McGuire, A. T., Stamatatos, L., & Pancera, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19231-9 · Cited by 162
Towards the next generation of biomedicines by site-selective conjugation
Hu, Q., Berti, F., & Adamo, R. (2016) · Chemical Society Reviews · doi:10.1039/c4cs00388h · Cited by 167
Yang, Y., Liu, F., Franc, V., Halim, L. A., Schellekens, H., & Heck, A. J. R. (2016) · Nature Communications · doi:10.1038/ncomms13397 · Cited by 152
Advanced Plant-Based Glycan Engineering
Montero‐Morales, L., & Steinkellner, H. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00081 · Cited by 135
A cell-free biosynthesis platform for modular construction of protein glycosylation pathways
Kightlinger, W., Duncker, K. E., Ramesh, A., Thames, A. H., Natarajan, A., Stark, J. C., Yang, A., Liang, L., Mrksich, M., DeLisa, M. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12024-9 · Cited by 135
Kopp, J., Slouka, C., Ulonska, S., Kager, J., Fricke, J., Oliver Spadiut, A., & Herwig, C. (2017) · Bioengineering · doi:10.3390/bioengineering5010001 · Cited by 120
Glycan-Based Cell Targeting To Modulate Immune Responses
Johannssen, T., & Lepenies, B. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.10.002 · Cited by 118
Abaandou, L., Quan, D. N., & Shiloach, J. (2021) · Cells · doi:10.3390/cells10071667 · Cited by 116
Barber, K. W., & Rinehart, J. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2572 · Cited by 101
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 103
Spahn, P. N., Hansen, A. H., Hansen, H. G., Arnsdorf, J., Kildegaard, H. F., & Lewis, N. E. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.10.007 · Cited by 99
Antibody glycoengineering strategies in mammalian cells
Wang, Q., Chung, C., Chough, S., & Betenbaugh, M. J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26567 · Cited by 95
Glycosylation control technologies for recombinant therapeutic proteins
Gupta, S. K., & Shukla, P. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9430-6 · Cited by 99
Glycan characterization of biopharmaceuticals: Updates and perspectives
Planinc, A., Bones, J., Dejaegher, B., Antwerpen, P. V., & Delporte, C. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.03.049 · Cited by 91
Direct quality control of glycoengineered erythropoietin variants
Čaval, T., Tian, W., Yang, Z., Clausen, H., & Heck, A. J. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05536-3 · Cited by 82
Using glyco-engineering to produce therapeutic proteins
Dicker, M., & Strasser, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1069271 · Cited by 73
Expression of eukaryotic membrane proteins in eukaryotic and prokaryotic hosts
Kesidis, A., Depping, P., Lodé, A., Vaitsopoulou, A., Bill, R. M., Goddard, A. D., & Rothnie, A. J. (2020) · Methods · doi:10.1016/j.ymeth.2020.06.006 · Cited by 85
Synthetic Glycobiology: Parts, Systems, and Applications
Kightlinger, W., Warfel, K. F., DeLisa, M. P., & Jewett, M. C. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00210 · Cited by 86
Extended O-GlcNAc on HLA Class-I-Bound Peptides
Marino, F., Bern, M. W., Mommen, G. P. M., Leney, A. C., den Brink, J. A. M. V. G.-V., Bonvin, A. M. J. J., Becker, C. H., van Els, C. A. C. M., & Heck, A. J. R. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06586 · Cited by 78
Gunnoo, S. B., & Madder, A. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00808a · Cited by 79
Small-molecule control of antibody N-glycosylation in engineered mammalian cells
Chang, M. M., Gaidukov, L., Jung, G., Tseng, W. A., Scarcelli, J. J., Cornell, R. J., Marshall, J. K., Lyles, J. L., Sakorafas, P., Chu, A. A., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0288-4 · Cited by 73
Progress in the development of subunit vaccines for gastrointestinal nematodes of ruminants
Matthews, J. B., Geldhof, P., Tzelos, T., & Claerebout, E. (2016) · Parasite Immunology · doi:10.1111/pim.12391 · Cited by 67
Customized protein glycosylation to improve biopharmaceutical function and targeting
Van Landuyt, L., Lonigro, C., Meuris, L., & Callewaert, N. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.11.017 · Cited by 66
Self-citationPlant specific N-glycans do not have proven adverse effects in humans
Shaaltiel, Y., & Tekoah, Y. (2016) · Nature Biotechnology · doi:10.1038/nbt.3556 · Cited by 67
Recombinant protein production from stable mammalian cell lines and pools
Hacker, D. L., & Balasubramanian, S. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.06.005 · Cited by 65
Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies
Rocamora, F., Peralta, A. G., Shin, S., Sorrentino, J., Wu, M. Y. M., Toth, E. A., Fuerst, T. R., & Lewis, N. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108206 · Cited by 67
Slouka, C., Kopp, J., Hutwimmer, S., Strahammer, M., Strohmer, D., Eitenberger, E., Schwaighofer, A., & Herwig, C. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0997-5 · Cited by 63
Stable mammalian producer cell lines for structural biology
Büssow, K. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.03.002 · Cited by 60
Harvey, D. J. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21530 · Cited by 61
Plant glyco-biotechnology on the way to synthetic biology
Loos, A., & Steinkellner, H. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00523 · Cited by 56
Cuccui, J., & Wren, B. W. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12321 · Cited by 55
Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria
Natarajan, A., Jaroentomeechai, T., Cabrera-Sánchez, M., Mohammed, J. C., Cox, E. C., Young, O., Shajahan, A., Vilkhovoy, M., Vadhin, S., Varner, J. D., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0595-9 · Cited by 53
Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds
Piron, R., Santens, F., Paepe, A. D., Depicker, A., & Callewaert, N. (2015) · Nature Biotechnology · doi:10.1038/nbt.3359 · Cited by 49
Self-citationImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Le, N. P. L., Bowden, T. A., Struwe, W. B., & Crispin, M. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.016 · Cited by 48
Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms
Matthews, C. B., Wright, C. M., Kuo, A., Colant, N., Westoby, M., & Love, J. C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26378 · Cited by 47
Systems glycobiology for glycoengineering
Spahn, P. N., & Lewis, N. E. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.08.004 · Cited by 46
On the glycosylation aspects of biosimilarity
Hajba, L., Szekrényes, Á., Borza, B., & Guttman, A. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.009 · Cited by 47
Plant glycoengineering for designing next-generation vaccines and therapeutic proteins
Strasser, R. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108197 · Cited by 43
Structure and Assembly Mechanism of the Signaling Complex Mediated by Human CSF-1
Félix, J., Munck, S. D., Verstraete, K., Meuris, L., Callewaert, N., Elegheert, J., & Savvides, S. N. (2015) · Structure · doi:10.1016/j.str.2015.06.019 · Cited by 45
Self-citationN-Glycosylation Fingerprinting of Viral Glycoproteins by xCGE-LIF
Hennig, R., Rapp, E., Kottler, R., Cajic, S., Borowiak, M., & Reichl, U. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_8 · Cited by 42
Modulating antibody effector functions by Fc glycoengineering
García-Alija, M., Moer, B. V., Sastre, D. E., Azzam, T., Du, J. J., Trastoy, B., Callewaert, N., Sundberg, E. J., & Guerin, M. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108201 · Cited by 43
Self-citationVilliger, T. K., Steinhoff, R., Ivarsson, M., Solacroup, T., Stettler, M., Broly, H., Krismer, J., Pabst, M., Zenobi, R., Morbidelli, M., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.04.039 · Cited by 41
Sequential Glycosylation of Proteins with Substrate-Specific N-Glycosyltransferases
Liang, L., Kightlinger, W., Prabhu, S. K., Hockenberry, A. J., Li, C., Wang, L., Jewett, M. C., & Mrksich, M. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b00021 · Cited by 41
Jin, Z., Kitajima, T., Dong, W., Huang, Y., Ren, W.-W., Guan, F., Chiba, Y., Gao, X., & Fujita, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.813030 · Cited by 40
Glasscock, C. J., Yates, L. E., Jaroentomeechai, T., Wilson, J. D., Merritt, J. H., Lucks, J. B., & DeLisa, M. P. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.04.014 · Cited by 40
Glycoengineering of CHO Cells to Improve Product Quality
Wang, Q., Yin, B., Chung, C., & Betenbaugh, M. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6972-2_2 · Cited by 42
Glycoengineering design options for IgG1 in CHO cells using precise gene editing
Schulz, M. A., Tian, W., Mao, Y., Coillie, J. V., Sun, L., Larsen, J. S., Chen, Y., Kristensen, C., Vakhrushev, S. Y., Clausen, H., et al. (2018) · Glycobiology · doi:10.1093/glycob/cwy022 · Cited by 41
Immobilized enzyme cascade for targeted glycosylation
Makrydaki, E., Donini, R., Krueger, A., Royle, K. E., Moya‐Ramírez, I., Kuntz, D. A., Rose, D. R., Haslam, S. M., Polizzi, K. M., & Kontoravdi, C. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01539-4 · Cited by 38
Glycoengineering Chinese hamster ovary cells: a short history
Donini, R., Haslam, S. M., & Kontoravdi, C. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200840 · Cited by 37
Exposing the molecular heterogeneity of glycosylated biotherapeutics
Schachner, L. F., Mullen, C., Phung, W., Hinkle, J. D., Beardsley, M. I., Bentley, T., Day, P., Tsai, C., Sukumaran, S., Baginski, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47693-8 · Cited by 36
Juárez, P., Virdi, V., Depicker, A., & Orzáez, D. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12541 · Cited by 37
Cell-Free Synthetic Glycobiology: Designing and Engineering Glycomolecules Outside of Living Cells
Jaroentomeechai, T., Taw, M. N., Li, M., Aquino, A. K., Agashe, N., Chung, S. S., Jewett, M. C., & DeLisa, M. P. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00645 · Cited by 35
Glycosylation profiles determine extravasation and disease-targeting properties of armed antibodies
Venetz, D., Hess, C., Lin, C., Aebi, M., & Neri, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416694112 · Cited by 33
Expression of Lectins in Heterologous Systems
Martínez-Alarcón, D., Blanco‐Labra, A., & García-Gasca, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020616 · Cited by 33
Nomura, K., Maki, Y., Okamoto, R., Satoh, A., & Kajihara, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02601 · Cited by 33
N‐glycan maturation mutants in Lotus japonicus for basic and applied glycoprotein research
Pedersen, C. T., Loke, I., Lorentzen, A. M., Wolf, S., Kamble, M., Kristensen, S. K., Munch, D., Radutoiu, S., Spillner, E., Roepstorff, P., et al. (2017) · The Plant Journal · doi:10.1111/tpj.13570 · Cited by 33
Nadeem, T., Khan, M. A., Ijaz, B., Ahmed, N., Rahman, Z. U., Latif, M. S., Ali, Q., & Rana, M. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0032 · Cited by 32
Magnetophoretic Conductors and Diodes in a 3D Magnetic Field
Abedini‐Nassab, R., Joh, D. Y., Triggiano, M. A., Baker, C. D., Chilkoti, A., Murdoch, D. M., & Yellen, B. B. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201503898 · Cited by 30
Are glycan biosensors an alternative to glycan microarrays?
Hushegyi, A., & Tkáč, J. (2014) · Analytical Methods · doi:10.1039/c4ay00692e · Cited by 28
Lepenies, B., & Seeberger, P. H. (2014) · Nature Biotechnology · doi:10.1038/nbt.2893 · Cited by 27
Claes, K., Vandewalle, K., Laukens, B., Laeremans, T., Vosters, O., Langer, I., Parmentier, M., Steyaert, J., & Callewaert, N. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00032 · Cited by 27
Self-citationInclusion Body Bead Size in E. coli Controlled by Physiological Feeding
Kopp, J., Slouka, C., Strohmer, D., Kager, J., Oliver Spadiut, A., & Herwig, C. (2018) · Microorganisms · doi:10.3390/microorganisms6040116 · Cited by 26
Chiang, A. W. T., Li, S., Spahn, P. N., Richelle, A., Kuo, C., Samoudi, M., & Lewis, N. E. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.08.008 · Cited by 25
Jung, J., Huy, N.-X., Kim, H.-B., Kim, N.-S., Giap, V., & Yang, M. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.03.033 · Cited by 25
Glycoengineering of HEK293 cells to produce high-mannose-type N-glycan structures
Ren, W., Jin, Z., Dong, W., Kitajima, T., Gao, X., & Fujita, M. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz032 · Cited by 24
Membrane traffic related to endosome dynamics and protein secretion in filamentous fungi
Higuchi, Y. (2021) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbab004 · Cited by 23
Recent advances in engineering yeast for pharmaceutical protein production
Fidan, Ö., & Zhan, J. (2015) · RSC Advances · doi:10.1039/c5ra13003d · Cited by 26
Herman, X., Far, J., Courtoy, A., Bouhon, L., Quinton, L., Pauw, E. D., Chaumont, F., & Navarre, C. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.634023 · Cited by 22
Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris
Wang, S., Rong, Y., Wang, Y., Kong, D., Wang, P. G., Chen, M., & Kong, Y. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-1280-0 · Cited by 22
Post-translational and transcriptional dynamics – regulating extracellular vesicle biology
Claridge, B., Kastaniegaard, K., Stensballe, A., & Greening, D. W. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1551135 · Cited by 21
New Mammalian Expression Systems
Zhu, J., & Hatton, D. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2016_55 · Cited by 22
The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits
Chen, R. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0389-z · Cited by 20
Waele, S. D., Vandenberghe, I. H. M., Laukens, B., Planckaert, S., Verweire, S., Bogaert, I. V., Soetaert, W., Devreese, B. V., & Ciesielska, K. (2017) · Protein Expression and Purification · doi:10.1016/j.pep.2017.10.016 · Cited by 20
Self-citationQuantitative glycomics using liquid phase separations coupled to mass spectrometry
Smith, J., Mittermayr, S., Váradi, C., & Bones, J. (2017) · The Analyst · doi:10.1039/c6an02715f · Cited by 19
Slouka, C., Kopp, J., Strohmer, D., Kager, J., Oliver Spadiut, A., & Herwig, C. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.03.014 · Cited by 19
Zhu, J., Ruan, Y., Fu, X., Zhang, L.-C., Ge, G.-S., Wall, J., Zou, T., Zheng, Y., Ding, N., & Hu, X.-J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00313 · Cited by 19
Cellular and Molecular Engineering of Glycan Sialylation in Heterologous Systems
Hombu, R., Neelamegham, S., & Park, S. (2021) · Molecules · doi:10.3390/molecules26195950 · Cited by 18
Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies
Bennett, L. D., Yang, Q., Berquist, B. R., Giddens, J. P., Ren, Z., Kommineni, V., Murray, R. C., White, E. L., Holtz, B. R., Wang, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020421 · Cited by 18
Hasan, M., Khakzad, H., Happonen, L., Sundin, A., Unge, J., Müeller, U., Malmström, J. A., Westergren‐Thorsson, G., Malmström, L., Ellervik, U., et al. (2020) · Chemical Science · doi:10.1039/d0sc05971d · Cited by 17
Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases
Trastoy, B., Du, J. J., García-Alija, M., Li, C., Klontz, E. H., Wang, L., Sundberg, E. J., & Guerin, M. E. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.11.016 · Cited by 16
Deglycosylating enzymes acting on N-glycans in fungi: Insights from a genome survey
Tzelepis, G. D., Karlsson, M., & Suzuki, T. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.08.022 · Cited by 17
Site‐Specific Protein Modification with Reducing Carbohydrates
Wu, Q., Dong, W., Miao, H., Wang, Q., Dong, S., & Xuan, W. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202116545 · Cited by 16
Saghaleyni, R., Malm, M., Moruzzi, N., Zrimec, J., Razavi, R., Wistbacka, N., Thorell, H., Pintar, A., Hober, A., Edfors, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110936 · Cited by 15
Chen, R., Cheng, K., Ning, Z., & Figeys, D. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03531 · Cited by 15
Shin, J., Lee, N., Song, Y., Park, J., Kang, T. J., Kim, S. C., Lee, G. M., & Byung-Kwan, C. (2015) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-015-0233-7 · Cited by 16
Kumar, R., Chhikara, B. S., Gulia, K., & Chhillar, M. (2020) · Molecular Omics · doi:10.1039/d0mo00085j · Cited by 14
Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase
Gludovacz, E., Maresch, D., de Carvalho, L. L., Puxbaum, V., Baier, L. J., Sützl, L., Guédez, G., Grünwald‐Gruber, C., Ulm, B., Pils, S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814244 · Cited by 12
Kozak, S., Bloch, Y., Munck, S. D., Mikula, A. M., Bento, I., Savvides, S. N., & Meijers, R. (2020) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798320013753 · Cited by 12
Thames, A. H., Moons, S. J., Wong, D. A., Boltje, T. J., Bochner, B. S., & Jewett, M. C. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00017 · Cited by 11
van Schie, L., Breedam, W. V., Roels, C., Schepens, B., Frank, M., Mehdipour, A. R., Laukens, B., Nerinckx, W., Santens, F., Devos, S., et al. (2023) · mAbs · doi:10.1080/19420862.2023.2210709 · Cited by 12
Self-citationAntibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo
Liew, P. X., Kim, J. H., Lee, W., & Kubes, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10420-z · Cited by 11
Metadata
- Authors
- Meuris, L., Santens, F., Elson, G., Festjens, N., Boone, M., Dos Santos, A., Devos, S., Rousseau, F., Plets, E., Houthuys, E., Malinge, P., Magistrelli, G., Cons, L., Chatel, L., Devreese, B., & Callewaert, N.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Light Chain Bioscience (Switzerland) (CH)
- Ghent University (BE)
- Corresponding author
- Callewaert, Nico
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2014-04-20
- Volume
- 32
- Issue
- 5
- Pages
- 485-489
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7039703
- OpenAlex
- W1965443132
- Cited by
- 141
- References
- 31
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 16 · 2019: 7 · 2018: 22 · 2017: 16 · 2016: 15 · 2015: 16 · 2014: 6
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek (G.0.541.08.N.10)
- Universiteit Gent
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- N-glycosylation, glycoengineering, recombinant protein expression, protein clearance, glycoprotein folding, biopharmaceuticals
- MeSH terms
- Animals, Glycosylation, Humans, Polysaccharides, Recombinant Proteins, Protein Engineering, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review